Literature DB >> 16231092

Human selenoproteins at a glance.

S Gromer1, J K Eubel, B L Lee, J Jacob.   

Abstract

The public perception of selenium has changed significantly over the last decades. Originally mainly known for its high toxicity, it was later recognized as an essential trace element and is now (despite its narrow therapeutic window) almost being marketed as a lifestyle drug. Indeed, some clinical and preclinical studies suggest that selenium supplementation may be beneficial in a large number of clinical conditions. However, its mode of action is unresolved in most of these cases. Selenocysteine - identified as the 21st amino acid used in ribosome-mediated protein synthesis - is incorporated in at least 25 specific, genetically determined human selenoproteins, many of which have only recently been discovered. Restoration of normal selenoprotein levels may be - apart from direct supranutritional effects - one possible explanation for the effects of selenium supplements. In this review we provide a brief but up-to-date overview of what is currently known about these 25 acknowledged human selenoproteins and their synthesis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16231092     DOI: 10.1007/s00018-005-5143-y

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  54 in total

1.  Metabolism of selenite in human lung cancer cells: X-ray absorption and fluorescence studies.

Authors:  Claire M Weekley; Jade B Aitken; Stefan Vogt; Lydia A Finney; David J Paterson; Martin D de Jonge; Daryl L Howard; Paul K Witting; Ian F Musgrave; Hugh H Harris
Journal:  J Am Chem Soc       Date:  2011-10-20       Impact factor: 15.419

2.  Regulation of the extracellular antioxidant selenoprotein plasma glutathione peroxidase (GPx-3) in mammalian cells.

Authors:  Filomena G Ottaviano; Shiow-Shih Tang; Diane E Handy; Joseph Loscalzo
Journal:  Mol Cell Biochem       Date:  2009-02-15       Impact factor: 3.396

Review 3.  Selenoproteins that function in cancer prevention and promotion.

Authors:  Dolph L Hatfield; Min-Hyuk Yoo; Bradley A Carlson; Vadim N Gladyshev
Journal:  Biochim Biophys Acta       Date:  2009-03-09

4.  Solid-phase synthesis of reduced selenocysteine tetrapeptides and their oxidized analogs containing selenenylsulfide eight-membered rings.

Authors:  Ludger A Wessjohann; Alex Schneider; Goran N Kaluđerović; Wolfgang Brandt
Journal:  Mol Divers       Date:  2013-06-01       Impact factor: 2.943

5.  Selenoprotein K binds multiprotein complexes and is involved in the regulation of endoplasmic reticulum homeostasis.

Authors:  Valentina A Shchedrina; Robert A Everley; Yan Zhang; Steven P Gygi; Dolph L Hatfield; Vadim N Gladyshev
Journal:  J Biol Chem       Date:  2011-10-20       Impact factor: 5.157

6.  Amblyomma maculatum SECIS binding protein 2 and putative selenoprotein P are indispensable for pathogen replication and tick fecundity.

Authors:  Khemraj Budachetri; Gary Crispell; Shahid Karim
Journal:  Insect Biochem Mol Biol       Date:  2017-07-21       Impact factor: 4.714

Review 7.  The influence of selenium on immune responses.

Authors:  Peter R Hoffmann; Marla J Berry
Journal:  Mol Nutr Food Res       Date:  2008-11       Impact factor: 5.914

8.  Selenium and thyroid autoimmunity.

Authors:  Roberto Negro
Journal:  Biologics       Date:  2008-06

9.  Osteo-chondroprogenitor-specific deletion of the selenocysteine tRNA gene, Trsp, leads to chondronecrosis and abnormal skeletal development: a putative model for Kashin-Beck disease.

Authors:  Charlene M Downey; Chelsea R Horton; Bradley A Carlson; Trish E Parsons; Dolph L Hatfield; Benedikt Hallgrímsson; Frank R Jirik
Journal:  PLoS Genet       Date:  2009-08-21       Impact factor: 5.917

10.  Silencing of genes involved in Anaplasma marginale-tick interactions affects the pathogen developmental cycle in Dermacentor variabilis.

Authors:  Katherine M Kocan; Zorica Zivkovic; Edmour F Blouin; Victoria Naranjo; Consuelo Almazán; Ruchira Mitra; José de la Fuente
Journal:  BMC Dev Biol       Date:  2009-07-16       Impact factor: 1.978

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.